# Amgen Inc. (AMGN) — Q4-2023 Earnings Results

**Report date:** 2024-02-06 (after market close)  
**Sector:** Health Care / Biotechnology  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/AMGN/earnings/Q4-2023

## Post-Earnings Brief

### Headline

Amgen Beats on EPS, Stock Down 1.83%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $4.71 | N/A | +1.16% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management expressed a cautious optimism about future growth. They are focusing on their product pipeline and operational improvements despite competitive challenges.

**Key quotes:**

> Management highlighted ongoing efforts to enhance product pipeline.

> They acknowledged competitive pressures but emphasized strong market position.

> Focus remains on innovation and operational efficiency.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Amgen's earnings report shows a slight beat on EPS, indicating better-than-expected profitability. However, the stock fell by 1.83% in reaction, likely due to the lack of revenue details and forward guidance. Investors may be concerned about competitive pressures and the absence of specific future targets.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/AMGN/earnings/Q4-2023_